Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by Wino115on Nov 20, 2023 11:02am
149 Views
Post# 35744335

Risk of Alzheimer's Disease May Inc With Hidden Belly Fat

Risk of Alzheimer's Disease May Inc With Hidden Belly Fat

https://www.newsweek.com/alzheimers-risk-linked-visceral-fat-1845098#:~:text=The%20scientists%20found%20that%20higher%20amyloid%20uptake%20in,connection%20being%20stronger%20in%20men%20than%20in%20women.

Higher levels of visceral fat—that surrounding the internal organs, hidden deep within the abdomen—are linked with changes in the brain, sometimes up to 15 years before any memory-loss symptoms of Alzheimer's begin. This is according to new research to be presented at the annual meeting of the Radiological Society of North America (RSNA) between November 26 and 29.

"This study highlights a key mechanism by which hidden fat can increase the risk of Alzheimer's disease," co-author Cyrus A. Raji said in a statement. He is an associate professor of radiology and neurology, and director of neuromagnetic resonance imaging at Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis, Missouri. "It shows that such brain changes occur as early as age 50, on average—up to 15 years before the earliest memory-loss symptoms of Alzheimer's occur."

<< Previous
Bullboard Posts
Next >>